Related Experiment Video
Updated: Jan 25, 2026

Author Spotlight: FISH as a Tool for Precise Gene Amplification Assessment in Cancer Specimens
Published on: July 12, 2024
Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast
Yazhen Zhu1, Dan Lu2, Maruja E Lira3
1Guangdong Provincial Hospital of Traditional Chinese Medicine (GPHTCM), Guangzhou, China.
Rationale:
Human epidermal growth factor receptor 2 (HER2) is a key driver of tumorigenesis, and over-expression as a result of HER2 gene amplification has been observed in a number of solid tumors. Recently HER2 has become an important biomarker for the monoclonal antibody treatment of HER2-positive metastatic breast and advanced gastric cancer. The HER2 targeting antibody trastuzumab treatment requires accurate measurement of HER2 levels for proper diagnosis. Droplet digital PCR (ddPCR) with highly direct, precise and absolute nucleic acid quantification could be used to detect HER2 amplification levels.
Objectives:
Our objective was to evaluate a robust, accurate and less subjective application of ddPCR for HER2 amplification levels and test the assay performance in clinical formalin-fixed paraffin-embedded (FFPE) breast and gastric carcinoma samples.
Methods:
Genomic DNA from HER2 amplified cell line SK-BR-3 was used to set up the ddPCR assays. The copy number of HER2 was compared to the chromosome 17 centromere reference gene (CEP17), expressed as HER2:CEP17 ratio. Genomic DNAs of FFPE specimens from 145 Asian patients with breast and gastric carcinomas were assayed using both standard methods, immunohistochemistry (IHC) and/or fluorescence in situ hybridization (FISH), and ddPCR.
Results:
Based on 145 clinical breast and gastric carcinoma cases, our study demonstrated a high concordance of ddPCR results to FISH and IHC. In breast cancer specimens, the ddPCR results had high concordance with FISH and IHC defined HER2 status with a sensitivity of 90.9% (30/33) and a specificity of 100% (77/77). In gastric cancer specimens that were concordant in both FISH and IHC, our assay was 95.5% concordant with FISH and IHC (21/22).
Conclusions:
ddPCR has the advantage of automation and also allows levels of HER2 amplification to be easily evaluated in large numbers of samples, and presents a potential option to define HER2 status.
Insights
Droplet digital PCR (ddPCR) accurately measures Human Epidermal growth factor Receptor 2 (HER2) amplification in breast and gastric cancers. This precise method shows high concordance with standard tests, offering a reliable option for HER2 status determination.
Area of Science:
- Oncology
- Molecular Diagnostics
- Biomarker Analysis
Background:
- Human Epidermal growth factor Receptor 2 (HER2) gene amplification drives tumorigenesis in various solid tumors.
- HER2 status is critical for targeted therapy, such as trastuzumab, in HER2-positive metastatic breast and advanced gastric cancers.
- Accurate HER2 quantification is essential for patient diagnosis and treatment selection.
Purpose of the Study:
- To evaluate droplet digital PCR (ddPCR) as a robust and accurate method for quantifying HER2 amplification levels.
- To assess the assay performance of ddPCR in clinical formalin-fixed paraffin-embedded (FFPE) breast and gastric carcinoma samples.
- To compare ddPCR results with established diagnostic methods like immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH).
Main Methods:
- ddPCR assays were developed using the HER2 amplified SK-BR-3 cell line.
- HER2 copy number was quantified relative to the chromosome 17 centromere reference gene (CEP17), yielding a HER2:CEP17 ratio.
- Genomic DNA from 145 Asian patients' FFPE breast and gastric carcinoma specimens was analyzed using ddPCR, IHC, and/or FISH.
Main Results:
- ddPCR demonstrated high concordance with FISH and IHC across 145 clinical cases.
- In breast cancer, ddPCR showed 90.9% sensitivity and 100% specificity compared to FISH and IHC.
- For gastric cancer specimens with concordant FISH and IHC results, ddPCR achieved 95.5% concordance.
Conclusions:
- ddPCR offers an automated and precise method for evaluating HER2 amplification levels.
- The assay's high accuracy and concordance make it a potential alternative for defining HER2 status in clinical settings.
- ddPCR facilitates the evaluation of HER2 amplification in large sample cohorts, supporting diagnostic workflows.
More Related Videos
07:43Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
Published on: July 29, 2017
10:16Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines
Published on: October 8, 2015
Related Concept Videos
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
Bacterial RNA Polymerase
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
Free-Radical Chain Reaction and Polymerization of Alkenes
Electron Transport Chains
The ETC is comprised of...
Fixing Double-strand Breaks